Intrathecal ketorolac reverses hypersensitivity following acute fentanyl exposure

Anesthesiology

Volumn 97, Issue 6, 2002, Pages 1641-1644

  Kang, Yoo Jin ^b   Vincler, Michelle ^b   Li, Xinhui ^b   Conklin, Dawn ^b   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; KETOROLAC;

ALLODYNIA; ANESTHESIA COMPLICATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANESTHETICS, INTRAVENOUS; ANIMALS; CYCLOOXYGENASE INHIBITORS; DRUG HYPERSENSITIVITY; FENTANYL; HYPERALGESIA; INJECTIONS, SPINAL; KETOROLAC; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 18744366328     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200212000-00046     Document Type: Article

References (26)

1. De Conno F, Caraceni A, Martini C, Spoldi E, Salvetti M, Ventafridda V: Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain 1991; 47:337-9
2. Sjogren P, Jonsson T, Jensen NH, Drenck NE, Jensen TS: Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993; 55:93-7
3. Miser AW, Chayt KJ, Sandlund JT, Cohen PS, Dothage JA, Miser JS: Narcotic withdrawal syndrome in young adults after the therapeutic use of opiates. Am J Dis Child 1986; 140:603-4
4. Laulin JP, Celerier E, Larcher A, Le Moal M, Simonnet G: Opiate tolerance to daily heroin administration: An apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 1999; 89:631-6
5. Célèrier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P, Simonnet G: Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 2000; 92:465-72
6. Chia YY, Liu K, Wang JJ, Kuo MC, Ho ST: Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth 1999; 46:872-7
7. Guignard B, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M: Acute opioid tolerance: Intvaoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93:409-17
8. Eisenach JC: Preemptive hyperalgesia, not analgesia? Anesthesiology 2000; 92:308-9
9. Chen I, Huang LY: Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 1991; 7:319-26
10. Dunbar SA, Pulai IJ: Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. J Pharmacol Exp Ther 1998; 284:678-86
11. Dunbar SA, Karamov IG, Buerkle H: The effect of spinal ibuprofen on opioid withdrawal in the rat. Anesth Analg 2000; 91:417-22
12. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR: Non-steroidal drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full ill vitro analysis. Proc Natl Acad Sci USA 1999; 96:7563-8
13. Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 7:1032-6
14. Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32:77-88
15. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
16. Vinik HR, Kissin I: Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998; 86:1307-11
17. Petersen KL, Jones B, Segredo V, Dahl JB, Rowbotham MC: Effect of remifentanil on pain and secondary hyperalgesia associated with the heat-capsaicin sensitization model in healthy volunteers. Anesthesiology 2001; 94:15-20
18. Powell KJ, Hosokawa A, Bell A, Sutak M, Milne B, Quirion R, Jhamandas K: Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance. Br J Pharmacol 1999; 127:631-44
19. Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257:1276-9
20. Malmberg AB, Yaksh TL: Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263:136-46
21. Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ: Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol 2000; 111:122-30
22. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD: Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 1997; 122:1593-604
23. 2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001; 21:5847-53
24. Versteeg HH, van Bergen en Henegouwen P, van Deventer SJ, Peppelenbosch MP: Cyclooxygenase-dependent signalling: Molecular events and consequences. FEBS Lett 1999; 445:1-5
25. 2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci 2000; 20:6714-20
26. 2-inhibitors in nerve-injured rats. Pain 1999; 82:65-72